NEW YORK (GenomeWeb News) — A research team at the University of Colorado, Boulder has received $14.6 million from the Defense Advanced Research Projects Agency to develop a system that will use microfluidics and mass spectrometry to determine how drugs and biological or chemical agents affect human cells.

The team at UC-Boulder's BioFrontiers Institute will use the cooperative agreement award to fund the Subcellular Pan-Omics for Advanced Rapid Threat Assessment (SPARTA) project, UC-Boulder said Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.